AI assistant
MYRIAD GENETICS INC — Director's Dealing 2022
Sep 27, 2022
32566_dirs_2022-09-27_e9a76213-54c2-4027-9ce1-0f9a0be76f36.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2022-09-25
Reporting Person: Riggsbee Richard Bryan (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-09-25 | Common Stock | F | 5263 | $18.69 | Disposed | 411035 | Direct |
| 2022-09-26 | Common Stock | F | 4543 | $18.41 | Disposed | 406492 | Direct |
Footnotes
F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 23, 2022.
F2: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2022.